Loading clinical trials...
Loading clinical trials...
Evaluating the additional value of Macrophage Migration Inhibitory factor (MIF) in cardiovascular diseases when assessed in clinical routine.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Hospital, Essen
NCT06563895 · Amyloidosis, Amyloid Cardiomyopathy, and more
NCT07516145 · Tricuspid Regurgitation (TR), Valvular Heart Diseases, and more
NCT06400004 · Heart Diseases
NCT06788275 · Percutaneous Coronary Intervention (PCI), Acute Myocardial Infarction, and more
NCT06590467 · Heart Diseases, ASD - Atrial Septal Defect, and more
University Hospital of Essen
Essen, North Rhine-Westphalia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions